Cargando…

Design and Synthesis of a Novel PLK1 Inhibitor Scaffold Using a Hybridized 3D-QSAR Model

Polo-like kinase 1 (PLK1) plays an important role in cell cycle progression and proliferation in cancer cells. PLK1 also contributes to anticancer drug resistance and is a valuable target in anticancer therapeutics. To identify additional effective PLK1 inhibitors, we performed QSAR studies of two s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Youri, Jung, Hoyong, Kim, Hyejin, Baek, Jihyun, Jun, Joonhong, Cho, Hyunwook, Im, Daseul, Hah, Jung-Mi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068361/ https://www.ncbi.nlm.nih.gov/pubmed/33917995 http://dx.doi.org/10.3390/ijms22083865

Ejemplares similares

Design and Synthesis of Aminopyrimidinyl Pyrazole Analogs as PLK1 Inhibitors Using Hybrid 3D-QSAR and Molecular Docking
por: Bhujbal, Swapnil P., et al.
Publicado: (2022)

Rational design and synthesis of 2-(1H-indazol-6-yl)-1H-benzo[d]imidazole derivatives as inhibitors targeting FMS-like tyrosine kinase 3 (FLT3) and its mutants
por: Im, Daseul, et al.
Publicado: (2022)

Discovery of 3-alkyl-5-aryl-1-pyrimidyl-1H-pyrazole derivatives as a novel selective inhibitor scaffold of JNK3
por: Oh, Youri, et al.
Publicado: (2019)

Discovery of a Potent and Selective JNK3 Inhibitor with Neuroprotective Effect Against Amyloid β-Induced Neurotoxicity in Primary Rat Neurons
por: Jun, Joonhong, et al.
Publicado: (2021)

Discovery of 1-Pyrimidinyl-2-Aryl-4,6-Dihydropyrrolo [3,4-d]Imidazole-5(1H)-Carboxamide as a Novel JNK Inhibitor
por: Jang, Miyoung, et al.
Publicado: (2020)

Computer-aided design and synthesis of 3-carbonyl-5-phenyl-1H-pyrazole as highly selective and potent BRAFV600E and CRAF inhibitor
por: Kim, Jinwoong, et al.
Publicado: (2019)

Conformational restriction of a type II FMS inhibitor leading to discovery of 5-methyl-N-(2-aryl-1H-benzo[d]imidazo-5-yl)isoxazole-4-carboxamide analogues as selective FLT3 inhibitors
por: Im, Daseul, et al.
Publicado: (2019)

Discovery of 5-methyl-N-(2-arylquinazolin-7-yl)isoxazole-4-carboxamide analogues as highly selective FLT3 inhibitors
por: Im, Daseul, et al.
Publicado: (2020)

A Perspective on the Development of c-Jun N-terminal Kinase Inhibitors as Therapeutics for Alzheimer’s Disease: Investigating Structure through Docking Studies
por: Cho, Hyunwook, et al.
Publicado: (2021)

Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR Approach
por: Bhujbal, Swapnil P., et al.
Publicado: (2021)

Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR Studies
por: Bhujbal, Swapnil P., et al.
Publicado: (2022)

Combined Pharmacophore Modeling, Docking, and 3D-QSAR Studies of PLK1 Inhibitors
por: Lu, Shuai, et al.
Publicado: (2011)

Molecular Basis for Unidirectional Scaffold Switching of Human Plk4 in Centriole Biogenesis
por: Park, Suk-Youl, et al.
Publicado: (2014)

Self-regulated mechanism of Plk1 localization to kinetochores: lessons from the Plk1-PBIP1 interaction
por: Lee, Kyung S, et al.
Publicado: (2008)

Nec‐1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice
por: Yang, Seung‐Hoon, et al.
Publicado: (2016)

Cep152 acts as a scaffold for recruitment of Plk4 and CPAP to the centrosome
por: Cizmecioglu, Onur, et al.
Publicado: (2010)

Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR Studies
por: Shahani, Vijay M., et al.
Publicado: (2010)

3D-QSAR Studies, Molecular Docking, Molecular Dynamic Simulation, and ADMET Proprieties of Novel Pteridinone Derivatives as PLK1 Inhibitors for the Treatment of Prostate Cancer
por: Er-rajy, Mohammed, et al.
Publicado: (2023)

3D-QSAR study of benzotriazol-1-yl carboxamide scaffold as monoacylglycerol lipase inhibitors
por: Afzal, Obaid, et al.
Publicado: (2014)

Retraction of “Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR Studies”
por: Shahani, Vijay M., et al.
Publicado: (2023)

Synthesis of acetamidosulfonamide derivatives with antioxidative and QSAR studies
por: Worachartcheewan, Apilak, et al.
Publicado: (2022)

Synthesis, 3D-QSAR, and Molecular Modeling Studies of Triazole Bearing Compounds as a Promising Scaffold for Cyclooxygenase-2 Inhibition
por: Elrayess, Ranza, et al.
Publicado: (2020)

2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors
por: Zhao, Manman, et al.
Publicado: (2017)

Synthesis of some novel coumarin isoxazol sulfonamide hybrid compounds, 3D-QSAR studies, and antibacterial evaluation
por: Esfahani, Sheida Nasr, et al.
Publicado: (2021)

The Centrosome-Specific Phosphorylation of Cnn by Polo/Plk1 Drives Cnn Scaffold Assembly and Centrosome Maturation
por: Conduit, Paul T., et al.
Publicado: (2014)

Synthesis, Antifungal Activity, Cytotoxicity and QSAR Study of Camphor Derivatives
por: Duan, Xinying, et al.
Publicado: (2022)

QSAR workbench: automating QSAR modeling to drive compound design
por: Cox, Richard, et al.
Publicado: (2013)

Can Universal Cash Transfer Save Newborns’ Birth Weight During the Pandemic?
por: Jung, Hoyong
Publicado: (2023)

Hybridizing Feature Selection and Feature Learning Approaches in QSAR Modeling for Drug Discovery
por: Ponzoni, Ignacio, et al.
Publicado: (2017)

Asterless amplifies Plk4
por: Short, Ben
Publicado: (2015)

Synthesis, characterized, QSAR studies and molecular docking of some phosphonates as COVID-19 inhibitors
por: Gholivand, Khodayar, et al.
Publicado: (2022)

The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma
por: Zhang, Zhiqi, et al.
Publicado: (2023)

ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage and activation in hematopoietic cell lines
por: Dufies, Maeva, et al.
Publicado: (2017)

Recent Advances in Fragment-Based QSAR and Multi-Dimensional QSAR Methods
por: Myint, Kyaw Zeyar, et al.
Publicado: (2010)

Methodology of aiQSAR: a group-specific approach to QSAR modelling
por: Vukovic, Kristijan, et al.
Publicado: (2019)

QSAR-Co-X: an open source toolkit for multitarget QSAR modelling
por: Halder, Amit Kumar, et al.
Publicado: (2021)

The chromatin remodeller RSF1 is essential for PLK1 deposition and function at mitotic kinetochores
por: Lee, Ho-Soo, et al.
Publicado: (2015)

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis
por: Kumar, Shiv, et al.
Publicado: (2015)

Re-investigating PLK1 inhibitors as antimitotic agents
por: Delacour, Quentin, et al.
Publicado: (2017)

Synthesis, antifungal activity, and QSAR studies of 1,6-dihydropyrimidine derivatives
por: Rami, Chirag, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fseoqmmdet01v9e2srkoralasv